Position in MDXG
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$599,171
+$29,412 QoQ
Shares Held
155,629
+7.9% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 226 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. MDXG ranks #170 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in MDXG
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $599,171 | 155,629 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $569,759 | 144,243 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,027,963 | 151,841 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,234,817 | 176,908 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,117,262 | 182,858 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,346,385 | 177,156 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,680,806 | 174,720 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,042,506 | 176,397 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,286,769 | 185,681 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,457,517 | 189,288 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,636,648 | 186,619 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,354,503 | 185,803 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,186,554 | 179,509 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $602,223 | 176,605 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $474,565 | 170,707 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $483,991 | 168,638 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $561,112 | 161,704 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $566,862 | 120,353 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $689,182 | 114,103 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $703,172 | 116,035 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,378,389 | 110,183 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||